These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
287 related items for PubMed ID: 11395972
1. Identifying the patient at risk for post-transplant lymphoproliferative disorder. Cockfield SM. Transpl Infect Dis; 2001 Jun; 3(2):70-8. PubMed ID: 11395972 [Abstract] [Full Text] [Related]
2. The Changing Epidemiology of Posttransplant Lymphoproliferative Disorder in Adult Solid Organ Transplant Recipients Over 30 Years: A Single-center Experience. Peters AC, Akinwumi MS, Cervera C, Mabilangan C, Ghosh S, Lai R, Iafolla M, Doucette K, Preiksaitis JK. Transplantation; 2018 Sep; 102(9):1553-1562. PubMed ID: 29485513 [Abstract] [Full Text] [Related]
3. Antiviral prophylaxis and the Epstein Barr virus-related post-transplant lymphoproliferative disorder. Davis CL, Harrison KL, McVicar JP, Forg PJ, Bronner MP, Marsh CL. Clin Transplant; 1995 Feb; 9(1):53-9. PubMed ID: 7742583 [Abstract] [Full Text] [Related]
5. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study. Hosseini-Moghaddam SM, Alhomayeed B, Soliman N, Weir MA, House AA. Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725 [Abstract] [Full Text] [Related]
6. The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience. Kogan-Liberman D, Burroughs M, Emre S, Moscona A, Shneider BL. J Pediatr Gastroenterol Nutr; 2001 Oct; 33(4):445-9. PubMed ID: 11698761 [Abstract] [Full Text] [Related]
7. Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey. San-Juan R, Manuel O, Hirsch HH, Fernández-Ruiz M, López-Medrano F, Comoli P, Caillard S, Grossi P, Aguado JM, ESGICH PTLD Survey Study Group,, European Study Group of Infections in Compromised Hosts (ESGICH) from the European Society of Microbiology and Infectious Diseases (ESCMID). Clin Microbiol Infect; 2015 Jun; 21(6):604.e1-9. PubMed ID: 25686696 [Abstract] [Full Text] [Related]
8. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients. San-Juan R, Comoli P, Caillard S, Moulin B, Hirsch HH, Meylan P, ESCMID Study Group of Infection in Compromised Hosts. Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():109-18. PubMed ID: 24475976 [Abstract] [Full Text] [Related]
10. The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder. Martinez OM, Krams SM. Transplantation; 2017 Sep; 101(9):2009-2016. PubMed ID: 28376031 [Abstract] [Full Text] [Related]
11. Induction of pre-transplant Epstein-Barr virus (EBV) infection by donor blood transfusion in EBV-seronegative recipients may reduce risk of post-transplant lymphoproliferative disease in adolescent renal transplant patients: report of two cases. Babel N, Gabdrakhmanova L, Hammer M, Rosenberger C, Oppert M, Volk HD, Reinke P. Transpl Infect Dis; 2005 Sep; 7(3-4):133-6. PubMed ID: 16390402 [Abstract] [Full Text] [Related]
12. Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naïve lung transplant recipient. Aris RM, Maia DM, Neuringer IP, Gott K, Kiley S, Gertis K, Handy J. Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1712-7. PubMed ID: 8970360 [Abstract] [Full Text] [Related]